ArticleFrontiers in oncology2020

Tailored Toxicity-Driven Administration of Vismodegib in Patients With Multiple or Locally Advanced Basal Cell Carcinoma: A Pilot Analysis.

Maria Chiara Tronconi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.